Data were collected from the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD), a multicenter, prospective cohort study in which new patients with end stage renal disease (ESRD) were monitored until transplantation or death.
SCD: Sickle cell disease; GFR: Glomerular filtration rate1; CKD: Chronic kidney disease; eGFR: Estimated glomerular filtration rate; HPLC: High performance liquid chromatography; ACS: Acute chest syndrome; MRI: Magnetic resonance imaging; ABPM: Ambulatory blood pressure monitoring; ESRD: End stage renal disease.
Abbreviation: BOCOMO study, body composition monitor study; ESRD, end stage renal disease; CBC, complete blood count; Kt/V, calculated using Daugirdas single pool equation; iPTH, intact parathyroid hormone; hsCRP, high sensitive C-reactive protein; UCG, ultrasonic cardiograph.
Nationally accepted guidelines for CKD care describe several aspects of stage-appropriate monitoring and treatment that can delay progression to end stage renal disease (ESRD).
Laboratory data, including serum electrolytes, especially potassium and calcium, pH, inflammatory markers, serum iron, proteinuria, hemoglobin, phosphates, and cystatin C, should be monitored, besides ECG QT intervals and T and R wave amplitude, in patients with end stage renal disease.
"They don't know early stage from end stage.
Figure 1 The three stage monitoring process.
ESRD = End stage renal disease.
Their relationship was in its end stages.
It is not a never ending stage.
